CUTIA-B (02487) Shareholder Transfers HK$122 Million Worth of Shares from Citibank to Morgan Stanley Hong Kong Securities
Stock News
Jan 27
According to the latest data from the Hong Kong Stock Exchange, on January 26th, a shareholder of CUTIA-B (02487) transferred shares from Citibank to Morgan Stanley Hong Kong Securities. The transferred shares had a market value of HK$122 million, accounting for 7.07% of the holdings.
Previously, CUTIA-B announced that its product CU-20101 (Botulinum Toxin Type A for Injection) achieved positive topline results in its Chinese Phase III clinical trial for improving moderate to severe glabellar lines.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.